Owain Parry is a seasoned Medical Science Liaison with extensive experience in the pharmaceutical industry, currently holding a position at ALK since January 2023, previously with Grünenthal Group from June 2019 to December 2022, focusing on Ireland. Expertise includes arranging medical webinars, copy approval, and providing medical support for various projects. Prior roles involved significant cross-functional collaboration and strategic planning in medical affairs, with a strong foundation in scientific communication established through positions at Norgine, Springer Nature, Sanofi, Bayer, and the National Poisons Information Service. Owain Parry holds a Master's degree in Toxicology from the University of Surrey and a Bachelor of Science in Biology from De Montfort University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices